<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01486407</url>
  </required_header>
  <id_info>
    <org_study_id>2011-13</org_study_id>
    <nct_id>NCT01486407</nct_id>
  </id_info>
  <brief_title>Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access.</brief_title>
  <official_title>An Observational Study of Intubating Conditions Comparing Intraosseous Vascular Access With Peripheral Intravenous Access for Drug Delivery in Rapid Sequence Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vidacare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vidacare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate using intraosseous vascular access and intravenous vascular access
      to give patients the necessary medications to perform rapid sequence intubation, for patients
      with airway difficulties. The investigators think the device operator will find the
      intraosseous and intravenous routes equal for drug delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This observational study will evaluate the intubating conditions of patients receiving rapid
      sequence intubation when receiving paralytic drug delivery via intravenous or intraosseous
      vascular access from the perspective of the medical professional performing rapid sequence
      intubation. The investigators believe that medical professionals will find equal intubating
      conditions for intravenous and intraosseous drug delivery.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    For poor enrollment
  </why_stopped>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time from first drug delivery to operator-perceived sufficient relaxation to perform endotracheal tube placement</measure>
    <time_frame>during rapid sequence intubation procedure, average expected time frame 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Intubation difficulty using the intubation difficulty scale</measure>
    <time_frame>during rapid sequence intubation procedure, average expected time frame 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Operator satisfaction with intubating conditions using visual analog scale</measure>
    <time_frame>during rapid sequence intubation procedure, average expected time frame 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Failure rate of endotracheal intubation and requirement for alternative airway management methods</measure>
    <time_frame>during rapid sequence intubation procedure, average time frame 30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of short-term catheter related complications for each technique</measure>
    <time_frame>during emergency department stay, average time frame 24 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2</enrollment>
  <condition>Airway Control</condition>
  <arm_group>
    <arm_group_label>Intravenous (IV) drug delivery</arm_group_label>
    <description>patients on whom intravenous vascular access has been established for the purpose of rapid sequence intubation drug delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intraosseous (IO) drug delivery</arm_group_label>
    <description>Patients on whom intraosseous vascular access has been established for rapid sequence intubation drug delivery.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in the emergency department with airway difficulties requiring rapid sequence
        intubation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Requires rapid sequence intubation

          -  Succinylcholine is chosen paralytic agent

          -  IV or IO access has been established for rapid sequence intubation

          -  For IV access patients, their rapid sequence intubation case is the next occurring IV
             rapid sequence intubation case following an enrolled IO RSI case.

        Exclusion Criteria:

          -  Vascular access other than IV or IO has been established
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen W Borron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University Health Science Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Christus Spohn Hospital Corpus Christi</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Tech University Health Science Center El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Reades R, Studnek JR, Vandeventer S, Garrett J. Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial. Ann Emerg Med. 2011 Dec;58(6):509-16. doi: 10.1016/j.annemergmed.2011.07.020.</citation>
    <PMID>21856044</PMID>
  </reference>
  <reference>
    <citation>Adnet F, Borron SW, Racine SX, Clemessy JL, Fournier JL, Plaisance P, Lapandry C. The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology. 1997 Dec;87(6):1290-7.</citation>
    <PMID>9416711</PMID>
  </reference>
  <reference>
    <citation>Leidel BA, Kirchhoff C, Bogner V, Braunstein V, Biberthaler P, Kanz KG. Comparison of intraosseous versus central venous vascular access in adults under resuscitation in the emergency department with inaccessible peripheral veins. Resuscitation. 2012 Jan;83(1):40-5. doi: 10.1016/j.resuscitation.2011.08.017. Epub 2011 Sep 3.</citation>
    <PMID>21893125</PMID>
  </reference>
  <reference>
    <citation>Deakin CD, Nolan JP, Sunde K, Koster RW. European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical therapies: automated external defibrillators, defibrillation, cardioversion and pacing. Resuscitation. 2010 Oct;81(10):1293-304. doi: 10.1016/j.resuscitation.2010.08.008.</citation>
    <PMID>20956050</PMID>
  </reference>
  <reference>
    <citation>Kleinman ME, de Caen AR, Chameides L, Atkins DL, Berg RA, Berg MD, Bhanji F, Biarent D, Bingham R, Coovadia AH, Hazinski MF, Hickey RW, Nadkarni VM, Reis AG, Rodriguez-Nunez A, Tibballs J, Zaritsky AL, Zideman D; Pediatric Basic and Advanced Life Support Chapter Collaborators. Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Pediatrics. 2010 Nov;126(5):e1261-318. doi: 10.1542/peds.2010-2972A. Epub 2010 Oct 18.</citation>
    <PMID>20956433</PMID>
  </reference>
  <reference>
    <citation>Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009 Feb;37(2):666-88. doi: 10.1097/CCM.0b013e31819323c6. Erratum in: Crit Care Med. 2009 Apr;37(4):1536. Skache, Sara [corrected to Kache, Saraswati]; Irazusta, Jose [corrected to Irazuzta, Jose].</citation>
    <PMID>19325359</PMID>
  </reference>
  <reference>
    <citation>Von Hoff DD, Kuhn JG, Burris HA 3rd, Miller LJ. Does intraosseous equal intravenous? A pharmacokinetic study. Am J Emerg Med. 2008 Jan;26(1):31-8.</citation>
    <PMID>18082778</PMID>
  </reference>
  <reference>
    <citation>Orlowski JP, Porembka DT, Gallagher JM, Lockrem JD, VanLente F. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs. Am J Dis Child. 1990 Jan;144(1):112-7.</citation>
    <PMID>1688484</PMID>
  </reference>
  <reference>
    <citation>Laurin EG, Sakles JC, Panacek EA, Rantapaa AA, Redd J. A comparison of succinylcholine and rocuronium for rapid-sequence intubation of emergency department patients. Acad Emerg Med. 2000 Dec;7(12):1362-9.</citation>
    <PMID>11099426</PMID>
  </reference>
  <reference>
    <citation>Perry JJ, Lee JS, Sillberg VA, Wells GA. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002788. doi: 10.1002/14651858.CD002788.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;10:CD002788.</citation>
    <PMID>18425883</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2011</study_first_submitted>
  <study_first_submitted_qc>December 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2011</study_first_posted>
  <last_update_submitted>January 31, 2013</last_update_submitted>
  <last_update_submitted_qc>January 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Airway management</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

